Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1 is a research paper published in The Journal of Experimental Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 307 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1S10OD018521-01
High Performance Computing Instrumentation for the Yale Center for Genome Analysi
National Institutes of Health
Grant: 5UL1TR001866-07
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
National Institutes of Health
Grant: 5UM1HG006504-07
Yale Center for Mendelian Genomics
National Institutes of Health
Grant: 5U24HG008956-02
NHGRI Genome Sequencing Program Coordinating Center
French National Research Agency (ANR)
Grant: ANR-20-CO11-0001
Genetic and immunological basis of auto-antibodies to type I IFNs underlying life-threatening COVID-19.
National Institutes of Health
Grant: 5R01AI088364-15
Inborn errors of immunity in children with herpes simplex encephalitis
Fields of Study
Keywords
Sustainable Development Goals